Rheumatology.net

Rheumatology Xagena

Search results for "Giant cell arteritis"

The results from the phase III study known as GiACTA, which evaluated Tocilizumab ( Actemra, RoActemra ), an anti-IL-6 receptor monoclonal antibody, in people with giant cell arteritis ( GCA ) were pr ...